Earlier this year, the FDA approved 2 new indications for Aquaflor. According to Merck, the supplemental approval increased ...

In the heart of Southwestern Kenya lies Lambwe Valley, where the Ruma National Park is also located. Here, wild animals such ...

The drug approval—and an associated approval by the FDA's Center for Veterinary Medicine of the ... GlaxoSmithKline (GSK), Merck and Wyeth, of Madison, New Jersey, continues to experience ...

Roche vet joins ... pharmaphorum.com. Merck KGaA is shaping up to take on Daiichi Sankyo and Ono Pharma in the market for tenosynovial giant cell tumour (TGCT) therapies after its drug candidate ...

Merck Veterinary Manual When a dog develops a pinched nerve in ... strict cage rest and the administration of anti-inflammatory drugs, pain relievers and muscle relaxers (given through your vet).

If you’re on the fence about investing in Merck ... veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

Merck has signed a licensing agreement worth up to $3.3 billion with Shanghai-based LaNova Medicines to develop, make and ...

Merck's undervalued stock presents growth opportunities with Keytruda and promising pipeline drugs, making it a Buy despite ...

Merck (MRK) stock will be in focus as company inks deal worth up to $3.3B to buy licensing rights to a cancer candidate ...

VEGF bispecifics. | Merck and BioNTech are buying Chinese biotechs to gain PD-(L)1/VEGF bispecifics. AstraZeneca's CEO argued ...

Merck & Co. licensed an experimental cancer antibody from a closely held Chinese company in a deal worth $588 million upfront ...